Literature DB >> 12601111

Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families.

G Lesca1, E Eymard-Pierre, F M Santorelli, R Cusmai, M Di Capua, E M Valente, J Attia-Sobol, H Plauchu, V Leuzzi, A Ponzone, O Boespflug-Tanguy, E Bertini.   

Abstract

OBJECTIVE: To report clinical, neuroradiologic, neurophysiologic, and genetic findings on 16 patients from 11 unrelated families with a remarkable uniform phenotype characterized by infantile ascending hereditary spastic paralysis (IAHSP).
METHODS: Sixteen patients from 11 families, originating from North Africa and Europe, who presented severe spastic paralysis and ascending progression were studied.
RESULTS: Spastic paraplegia started in the first 2 years of life in most patients and extended to the upper limbs by the end of the first decade. The disease progressed to tetraplegia, anarthria, dysphagia, and slow eye movements in the second decade. The clinical course showed a long survival and preservation of intellectual skills. Clinical, neuroradiologic, and neurophysiologic findings were consistent with a relatively selective early involvement of the corticospinal and corticobulbar pathways. No signs of lower motor neuron involvement were observed, whereas motor evoked potentials demonstrated predominant involvement of the upper motor neurons. MRI was normal in young patients but showed brain cortical atrophy in the oldest, predominant in the motor areas, and T2-weighted bilateral hyperintense signals in the posterior arm of the internal capsule. The ALS2 gene, recently found mutated in consanguineous Arabic families with either an ALS2 phenotype or a juvenile-onset primary lateral sclerosis, was analyzed. Alsin mutations were found in only 4 of the 10 families, whereas haplotype analysis excluded the ALS2 locus in one family.
CONCLUSIONS: The syndrome of IAHSP is genetically heterogeneous, and no clinical sign can help to distinguish patients with and without Alsin mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12601111     DOI: 10.1212/01.wnl.0000048207.28790.25

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Clinical presentation and natural history of infantile-onset ascending spastic paralysis from three families with an ALS2 founder variant.

Authors:  Mayada Helal; Neda Mazaheri; Bita Shalbafan; Reza Azizi Malamiri; Nafi Dilaver; Rebecca Buchert; Javad Mohammadiasl; Neda Golchin; Alireza Sedaghat; Mohammad Yahya Vahidi Mehrjardi; Tobias B Haack; Olaf Riess; Wendy K Chung; Hamid Galehdari; Gholamreza Shariati; Reza Maroofian
Journal:  Neurol Sci       Date:  2018-08-21       Impact factor: 3.307

2.  Maternal uniparental heterodisomy with partial isodisomy of a chromosome 2 carrying a splice acceptor site mutation (IVS9-2A>T) in ALS2 causes infantile-onset ascending spastic paralysis (IAHSP).

Authors:  Thilo Herzfeld; Nicole Wolf; Pia Winter; Holger Hackstein; Daniel Vater; Ulrich Müller
Journal:  Neurogenetics       Date:  2008-09-23       Impact factor: 2.660

3.  Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease.

Authors:  Koji Yamanaka; Christine Vande Velde; Eleonore Eymard-Pierre; Enrico Bertini; Odile Boespflug-Tanguy; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

4.  Troyer syndrome revisited. A clinical and radiological study of a complicated hereditary spastic paraplegia.

Authors:  Christos Proukakis; Harold Cross; Heema Patel; Michael A Patton; Alan Valentine; Andrew H Crosby
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

5.  The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset.

Authors:  Isabelle Maystadt; René Rezsöhazy; Martine Barkats; Sandra Duque; Pascal Vannuffel; Sophie Remacle; Barbara Lambert; Mustapha Najimi; Etienne Sokal; Arnold Munnich; Louis Viollet; Christine Verellen-Dumoulin
Journal:  Am J Hum Genet       Date:  2007-05-16       Impact factor: 11.025

6.  Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort.

Authors:  N Ticozzi; V Silani; A L LeClerc; P Keagle; C Gellera; A Ratti; F Taroni; T J Kwiatkowski; D M McKenna-Yasek; P C Sapp; R H Brown; J E Landers
Journal:  Neurology       Date:  2009-09-09       Impact factor: 9.910

7.  MR imaging findings in autosomal recessive hereditary spastic paraplegia.

Authors:  R Hourani; T El-Hajj; W H Barada; M Hourani; B I Yamout
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-04       Impact factor: 3.825

8.  ALS2 mutations: juvenile amyotrophic lateral sclerosis and generalized dystonia.

Authors:  Una-Marie Sheerin; Susanne A Schneider; Lucinda Carr; Guenther Deuschl; Franziska Hopfner; Maria Stamelou; Nicholas W Wood; Kailash P Bhatia
Journal:  Neurology       Date:  2014-02-21       Impact factor: 9.910

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.